Winter 2013 2014

Your 9 a.m. appointment walks in. He’s an overweight executive who tells you that he has been trying to lose weight, but he does not have the time to go to the gym or prepare healthy meals. But sitting in front of you during the office visit, he fields two phone calls, fires off three text... more

5
Average: 5 (1 vote)

It is with great pride and excitement that I compose this chapter message. Conveniently, this issue of Lipid Spin falls midway through my year as President of NELA, and therefore provides a perfect opportunity to update you on where we are, and where we are going. The summer months were a time of... more

5
Average: 5 (1 vote)

Changed lifestyles and diet have been associated with the current obesity epidemic. Pharmacologic interventions date back to the Greco-Roman era when laxatives coupled with exercise and other modalities to facilitate weight loss were prescribed or used. Many still remember the use of the following... more

0
No votes yet

Introduction: Obesity is a complex multifactoral chronic disease that develops from an interaction between genetics and the environment. The development of obesity involves the integration of social, behavioral, cultural, physiological, metabolic and genetic factors. Treatment of obesity should... more

0
No votes yet

Multicellular organisms depend on two central mechanisms for their survival: the ability to store energy to prevent starvation and the ability to fight infection. Adipocytes in higher organisms are reminiscent of the integrated function seen in lower organisms such as the fat body of the Drosophila... more

5
Average: 5 (1 vote)

This issue sponsored by the Northeast Lipid Association Featuring: "New Pharmacologic Approaches to Obesity" and "The Adipocyte: Friend or Foe?"  

4.666665
Average: 4.7 (3 votes)

We report the case of a young girl who presented with classic type III hyperlipoproteinemia to emphasize the importance of clarifying the lipid diagnoses, to illustrate the key features of this uncommon condition, and to demonstrate the potency of non-pharmacologic therapy in improving both... more

1
Average: 1 (1 vote)

David Capuzzi, MD, PhD, FNLA currently works with the cardiology group at the Lankenau Medical Center (Main Line Health) as an advisor to the cardiovascular disease prevention program, where he participates in clinical research and the cardiology fellows training program. Dr. Capuzzi values this... more

1
Average: 1 (1 vote)

It has been a busy—and rewarding—six months since I took over as President of the NLA. It is extremely gratifying to see so many projects that were discussed in the Board’s Strategic Plan taking shape. In our efforts to streamline processes and refine our organizational structure... more

1
Average: 1 (1 vote)

Let’s not confuse health care cost and health. Health care cost is the amount of money spent predominantly for the diagnosis and treatment of people with an acute illness or a chronic disease. The cost is related to the number of encounters and the cost per encounter. It is estimated that one... more

0
No votes yet